Mindset Pharma Inc.
OTC: MSSTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James Andre-Charles Lanthier
- Headquarters
- Toronto, Canada
- IPO year
- 2021
- Market cap
- $54.5M
- Website
- https://www.mindsetpharma.com
Loading MSSTF…
Loading profile data…Frequently asked questions about MSSTF
What does Mindset Pharma Inc. (MSSTF) do?
Mindset Pharma Inc., headquartered in Toronto, Canada, specializes in researching, developing, and commercializing psychedelic therapeutics. These innovative treatments are designed to address neurological and psychiatric conditions for patients in Canada. A primary focus for the company is the ongoing development of MSP-1014, an investigational...
Where does MSSTF trade?
Mindset Pharma Inc. (MSSTF) trades on the Other OTC.
What sector is MSSTF in?
Mindset Pharma Inc. (MSSTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Mindset Pharma Inc.?
James Andre-Charles Lanthier is the chief executive officer of Mindset Pharma Inc. (MSSTF).
Where is Mindset Pharma Inc. headquartered?
Mindset Pharma Inc. is headquartered in Canada.
Does MSSTF pay a dividend?
Mindset Pharma Inc. (MSSTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MSSTF go public?
Mindset Pharma Inc. (MSSTF) completed its initial public offering in 2021.